Antimicrobial-potentiated colorectal cancer therapy with synchronized tumoricidal immunity via a self-deliverable nanopeptide
{{output}}
As one of the core pathogens of colorectal cancer (CRC), fusobacterium nucleatum (Fn) contributes to tumor progression, drug-resistance, and immunosuppressive microenvironment, resulting in low therapeutic outcomes. Developing multifunctional nanodrugs capable... ...
